Bolin Chen

发表

Inhibition of Pim-1 Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice

Yan Zhao, Yue-ming Shen, Gui-ying Zhang, 2012, Digestive Diseases and Sciences.

MicroRNA-29 b regulates osteopontin dependent proliferation function and cell cycle in esophageal cancer lines

Lin Wu, Zhen Luo, Juan Du, 2017 .

LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway

Min Yang, Bolin Chen, Li Xu, 2020, BMC Pulmonary Medicine.

In-depth genomic characterization of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients.

Jun Liu, Yajie Xiao, Zhikun Zhao, 2021, Journal of Clinical Oncology.

Wnt inhibitory factor 1 ameliorated diabetic retinopathy through the AMPK/mTOR pathway‐mediated mitochondrial function

Wei Tan, Bolin Chen, Jing Zou, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Case Report: Tissue Origin Identification for Cancer of Unknown Primary: Gene Expression Profiling Approach

Qian Gong, Bolin Chen, Qianzhi Wang, 2021, Frontiers in Oncology.

Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma

Pei Yang, Lin Wu, Bolin Chen, 2022, Frontiers in Oncology.

The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice

Yue-ming Shen, Gui-ying Zhang, Mei-hua Xu, 2012, Parasitology.

Osteopontin expression is associated with hepatopathologic changes in Schistosoma japonicum infected mice.

Yue-ming Shen, Gui-ying Zhang, Huan Gu, 2011, World journal of gastroenterology.

Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects

Jia Li, Gui-ying Zhang, Huan Gu, 2012, Experimental and therapeutic medicine.

Wnt inhibitory 1 ameliorates neovascularization and attenuates photoreceptor injury in an oxygen‐induced retinopathy mouse model

Wei Tan, Bolin Chen, Jing Zou, 2022, BioFactors.

Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study

Li-Yu Daisy Liu, Yucheng Tang, Lin Wu, 2022, Cancer medicine.

Clinical and genomic features of Chinese lung cancer patients with germline mutations

X. Yi, Y. Guan, Ling Yang, 2019, Nature Communications.

Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients

Yajie Xiao, Zhikun Zhao, Dongfang Wu, 2022, Cancer cell international.

Abstract. Although antibodies targeting the immune check‐ point protein programmed death‐1 (PD‐1) exert therapeutic effects in patients with primary or metastatic non‐small cell

Xu Li, Min Yang, X. Fang, 2021 .

Next‐generation sequencing assisted diagnosis of cervical metastasis in EGFR‐mutated lung adenocarcinoma: A case report

Lin Wu, Bolin Chen, Kang Li, 2021, Thoracic cancer.

RKIP and 14-3-3ε Exert an Opposite Effect on Human Gastric Cancer Cells SGC7901 by Regulating the ERK/MAPK Pathway Differently

Jia Li, Gui-ying Zhang, Ting Liu, 2013, Digestive Diseases and Sciences.

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy

Lin Wu, Liyu Liu, Bolin Chen, 2020, Frontiers in Oncology.

Dacomitinib induces objective responses in metastatic brain lesions of patients with EGFR-mutant non-small-cell lung cancer: A brief report.

Yong Chen, Lin Wu, Bolin Chen, 2020, Lung cancer.

Peripheral blood biomarkers associated with outcome in non-small cell lung cancer patients treated with nivolumab and durvalumab monotherapy.

Lin Wu, Bolin Chen, Jingyi Wang, 2020 .

The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort study

Li-Yu Daisy Liu, A. Cardona, Bolin Chen, 2021, Translational lung cancer research.

OPN Promotes Cell Proliferation and Invasion through NF-κB in Human Esophageal Squamous Cell Carcinoma

Jie Peng, Bolin Chen, Li Xu, 2022, Genetics research.

Min Yang, Liyu Liu, Bolin Chen, 2021, Oncology letters.

MiR-21/Sonic Hedgehog (SHH)/PI3K/AKT Pathway is Associated with NSCLC of Primary EGFR-TKI Resistance

Li-Yu Daisy Liu, Bolin Chen, Qianzhi Wang, 2022, ONCOLOGIE.

Comparative efficacy and safety of pemetrexed and crizotinib in Chinese patients with advanced lung cancer: A preliminary clinical trial

Lin Wu, Bolin Chen, Li Xu, 2019 .

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

Weiyue Gu, Lin Wu, Bolin Chen, 2023, Scientific reports.

IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway

Bolin Chen, Jia Li, Y. Kong, 2023, Epigenetics.

IGF2BP1 enhances the stability of SIK2 mRNA through m6A modification to promote non-small cell lung cancer progression.

Bolin Chen, Yan Xu, Jia Li, 2023, Biochemical and Biophysical Research Communications - BBRC.

M2 macrophage exosomal LINC01001 promotes non-small cell lung cancer development by affecting METTL3 and glycolysis pathway

Bolin Chen, Jia Li, Y. Kong, 2023, Cancer Gene Therapy.

Inhibition of inflammation and infiltration of M2 macrophages in NSCLC through the ATF3/CSF1 axis: Role of miR‐27a‐3p

Bin Zhou, Bolin Chen, Li Xu, 2023, International journal of experimental pathology.

Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study

Bolin Chen, Qianzhi Wang, X. Pu, 2024, EClinicalMedicine.

Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study

Lin Wu, Bolin Chen, X. Pu, 2023, BMC Cancer.

A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.

Baiyong Li, Lin Wu, Bolin Chen, 2023, British journal of cancer.

Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study

Piao Zheng, Bolin Chen, Kuipo Yan, 2024, Heliyon.